Caremark, US FTC agree to settle insulin price-fixing claims
Caremark and the US Federal Trade Commission have agreed to settle the agency’s insulin price-fixing claims in an agreement the agency said will bring billions in savings to patients and consumers,...To view the full article, register now.
Already a subscriber? Click here to view full article